胆管细胞癌的诊断及治疗指南.pdfVIP

Downloaded from on November 10, 2013 - Published by Guidelines Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update Shahid A Khan,1 Brian R Davidson,2 Robert D Goldin,3 Nigel Heaton,4 John Karani,4 Stephen P Pereira,5 William M C Rosenberg,5 Paul Tait,6 Simon D Taylor-Robinson,1 Andrew V Thillainayagam,1 Howard C Thomas,1 Harpreet Wasan7 1Department of Hepatology and ABSTRACT C: level 4 studies or extrapolations from level 2 or 3 Gastroenterology Section, The British Society of Gastroenterology guidelines on the studies. Imperial College London, management of cholangiocarcinoma were originally D: level 5 evidence or inconsistent or inconclusive London, UK 2Department of Hepatobiliary published in 2002. This is the first update since then and studies of any level. Surgery, Division of Medicine, is based on a comprehensive review of the recent University College London, literature, including data from randomised controlled EPIDEMIOLOGY London, UK trials, systematic reviews, meta-analyses, cohort, 3Department of Medicine and CC is the second commonest primary liver Department of Histopathology, prospective and retrospective studies. tumour worldwide, after hepatocellular carcinoma Imperial College London,